The importance of diabetic neuropathy screening in the United Health System an integrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v12i4.41053

Keywords:

Diabetes mellitus; Public health; Neuropathy diabetic.

Abstract

Diabetic neuropathy is a feeling of diabetes mellitus resulting from nerve damage caused by the hyperglycemic state in the body, generating long-term deficiencies. Disease diagnosed late in the public health system (SUS). The aim of the study was to show the importance of early implementation of diabetic neuropathy screening in the SUS, seeking to prevent complications and establish effective treatment measures. This is an integrative review, where articles researched during 3 months, dated between 2015 and 2022 were used. The inclusion criteria in the analysis sample were: 1) articles with publication data from 2015; 2) articles recognized by experts in the field of family medicine and neurology. Exclusion criteria were: duplicate articles, monographs, course conclusion works and book chapters. Thus, much of the research suggests that most of the symptoms of diabetic neuropathy appear progressively and slowly, making it difficult to diagnose early. Thus, an effective strategy for the public health program is to prevent and control diabetes, in addition to using innovative screening methods, such as frequent sensitivity tests using monofilaments, tuning forks, biotensiometers and the neuropathic impairment score, which are essential for suspected pathogenesis.

References

Binns-Hall, O., Selvarajah, D., Sanger, D., Walker, J., Scott, A., & Tesfaye, S. (2018). One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot. Diabetic Medicine. 35(7), 887–894.

De Lima, L. R., Stival, M. M., Funghetto, S. S., Volpe, C. R. G., Rehem, T. C. M. S. B., Santos, W. S., & Funez, M. I. (2019). Menor qualidade de vida, dor em membros inferiores com características neuropáticas, sexo feminino e controle metabólico ineficaz são preditores de sintomas depressivos em pacientes com diabetes mellitus tipo 2 atendidos na atenção primária. Jornal Internacional de Diabetes em Países em Desenvolvimento. 39 , 463-470.

Feldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019). Diabetic neuropathy. Nature Reviews Disease Primers. 5(1), 41.

Hamasaki, H., & Hamasaki, Y. (2017). Neuropatia diabética avaliada por um novo dispositivo: a condução do nervo sural está associada ao controle glicêmico e ao índice de pressão tornozelo-braquial em pacientes japoneses com diabetes. Frontiers in endocrinology. 8 , 203.

International Diabetes Federation. (2015). IDF diabetes atlas. Brussels International Diabetes Federation.

Isomura, T., Sumitani, M., Matsudaira, K., Kawaguchi, M., Inoue, R., Hozumi, J., Tanaka, T., Oshima, H., Mori, K., Taketomi, S., Inui, H., Tahara, K., Yamagami, R., & Hayakawa, K. (2017). Development of the Japanese version of the Leeds Assessment of the Neuropathic Symptoms and Signs Pain Scale: diagnostic utility in a clinical setting. Pain Practice. 17(6), 800-807.

Lee, J. A., Halpern, E. M., Lovblom, L. E., Yeung, E., Bril, V., & Perkins, B. A. (2018). Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy. PloS one. 9(1), e86515.

Liu, X., Xu, Y., An, M., & Zeng, Q. (2019). The risk factors for diabetic peripheral neuropathy: a meta-analysis. PloS one. 14(2), e0212574.

Lorenzini, N., Díaz, C., & Quintana, T. (2020). Prueba diagnóstica de disfunción sudomotora en la detección precoz de la neuropatía diabética. Revista Médica de Chile. 148(1), 54–59.

Ministério Da Saúde. (n.d.). Brasília -DF 2016. http://189.28.128.100/dab/docs/portaldab/publicacoes/manual_do_pe_diabetico.pdf.

Nascimento, O. J. M. D., Pupe, C. C. B., & Cavalcanti, E. B. U. (2016). Neuropatia diabética. Revista Dor. 17, 46-51.

Oggiam, D. S., Kusahara, D. M., & Gamba, M. A. (2021). Rastreamento de dor neuropática para diabetes mellitus: uma análise conceitual. BrJP. 4, 77-86.

Ponirakis, G., Fadavi, H., Petropoulos, I. N., Azmi, S., Ferdousi, M., Dabbah, M. A., Kheyami, A., Alam, U., Asghar, O., Marshall, A., Tavakoli, M., Al-Ahmar, A., Javed, S., Jeziorska, M., & Malik, R. A. (2015). Automated quantification of neuropad improves its diagnostic ability in patients with diabetic neuropathy. Journal of diabetes research. 2015, 1-7.

Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2016). Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes care. 40(1), 136-154.

Ramos, T. T. O., dos Santos, M. C. Q., Lins, B. S., de Melo, É. C. A., dos Santos, S. M. P., & Noronha, J. A. F. (2020). Avaliação da perda da sensibilidade protetora plantar como diagnóstico precoce da neuropatia diabética. Brazilian Journal of Development. 6(5), 27500-27514.

Rolim, L. C., Thyssen, P. J., Flumignan, R. L., Andrade, D. C. de, Dib, S. A., & Bertoluci, M. (2022). Diagnóstico e tratamento da neuropatia periférica diabética. Diretriz Oficial Da Sociedade Brasileira de Diabetes.

Schaper, N. C., Van Netten, J. J., Apelqvist, J., Bus, S. A., Hinchliffe, R. J., & Lipsky, B. A. (2019). Diretrizes do IWGDF sobre a prevenção e o tratamento de pé diabético. Lançamento da Tradução Brasileira das Diretrizes IWGDF, (34º).

Vaitkus, A., & Šipylaitė, J. (2021). Sensory Perception in Lumbosacral Radiculopathy with Radicular Pain: Feasibility Study of Multimodal Bedside-Suitable Somatosensory Testing. Acta Medica Lituanica. 28(1), 97.

Xavier, A. T. D. F., Bittar, D. B., & Ataíde, M. B. C. D. (2019). Crenças no autocuidado em diabetes: implicações para a prática. Texto & contexto-enfermagem. 18, 124-130.

Yazdanpanah, L., Shahbazian, H., Nazari, I., Arti, H. R., Ahmadi, F., Mohammadianinejad, S. E., Cheraghian, B., & Hesam, S. (2018). Incidence and Risk Factors of Diabetic Foot Ulcer: A Population-Based Diabetic Foot Cohort (ADFC Study)—Two-Year Follow-Up Study. International Journal of Endocrinology. 2018, 1–9.

Zhao, N., Xu, J., Zhou, Q., Li, X., Chen, J., Zhou, J., Zhou, F., & Liang, J. (2021). Application of the Ipswich Touch Test for diabetic peripheral neuropathy screening: a systematic review and meta-analysis. BMJ open. 11(10), e046966.

Published

04/04/2023

How to Cite

ALVES, M. L. M. .; MENEZES, I. C. G. .; MOREIRA, N. G. .; CAMPOS, A. L. B. . The importance of diabetic neuropathy screening in the United Health System an integrative review. Research, Society and Development, [S. l.], v. 12, n. 4, p. e12212441053, 2023. DOI: 10.33448/rsd-v12i4.41053. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/41053. Acesso em: 23 may. 2024.

Issue

Section

Health Sciences